Second Line of Defence is innate form of non specific defence that removes pathogen entered into the body after bypassing first line of defense by means of defensive cells, proteins, fever and inflammation
The
primary defensive cells in innate immune response are the Professional
phagocytes. Macrophages, neutrophils and dendritic cells are called
professional phagocytes.
How macrophages and other cells of innate immune response recognize pathogens?
Pathogen-Associated
Molecular Patterns (PAMPs)
PAMPs
include carbohydrate,
polypeptide, and nucleic acid “signatures” that are expressed by viruses,
bacteria, and parasites. This helps immune cells for self-non self recognition.
These signatures are present only on pathogen so that self non self cells
recognition is possible. Microbes of different biochemical composition and with entirely different life
cycles are recognized by relatively similar mechanisms by host PRRs.
Examples
of PAMPs: flagellin protein that makes bacterial flagella, lipopolysaccharide
layer of gram negative bacteria, peptidoglycan of bacterial cell wall, zymozan
of yeast cell wall, nucleic acids of both bacteria and viruses etc.
Pattern
Recognition Receptors (PRRs)
The
immune cells has specific cell surface receptors
called pattern recognition receptors(PRRs) that recognize pathogen-associated
molecular patterns (PAMPs). Once recognized or binding of PAMPs to PRR transmits
intracellular signals leading to the transcription and translation of chemical messengers
like cytokines or anti viral proteins like interferon. This activation triggers
phagocytosis of pathogen by professional phagocytes.
Cytosolic
PRRs, that recognize PAMPs inside cell include retinoid acid-inducible gene I
(RIG-I)-like receptors (RLRs) and nucleotide-binding oligomerization domain
(NOD)-like receptors (NLRs).
Examples
of PRR include Toll like receptors (TLRs), scavenging receptors etc.
TLR2
binds to LPS, TLR 5 recognizes flagellin
Reference:
Mogensen T. H. (2009). Pathogen
recognition and inflammatory signaling in innate immune defenses. Clinical
microbiology reviews, 22(2), 240–273. https://doi.org/10.1128/CMR.00046-08